Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
---|---|---|---|---|---|---|
FHTX | Foghorn Therapeutics Inc. | Chief Financial Officer | $719K | Jan 16, 2024 | ||
PRME | Prime Medicine, Inc. | Chief Financial Officer | May 17, 2024 |
Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
---|